Novartis (NVS) – cijena dionice i vijesti

Simboli Simboli	Cijena	Promjena	Postotna promjena	Trend	Prethodna zadnja	Otvori	Najviša	Najniža	Količina	Trž. kap.
SIXB Materials SIXB Materials	SIXB −0,63%	1.093,66	−6,91	−0,63%	—	1.100,57	1.098,94	1.103,80	1.084,24	—	—
SIXC Communications SIXC Communications	SIXC −0,23%	603,74	−1,41	−0,23%	—	605,15	605,15	606,69	602,76	—	—
SIXE Energy SIXE Energy	SIXE +1,46%	1.212,65	+17,46	+1,46%	—	1.195,19	1.204,71	1.221,69	1.204,71	—	—
SIXI Industrials SIXI Industrials	SIXI −0,97%	1.723,08	−16,83	−0,97%	—	1.739,91	1.734,50	1.734,50	1.710,67	—	—
SIXM Financials SIXM Financials	SIXM +0,42%	641,23	+2,67	+0,42%	—	638,56	640,21	645,32	639,66	—	—
SIXR Staples SIXR Staples	SIXR +0,81%	838,32	+6,75	+0,81%	—	831,57	840,48	844,16	834,54	—	—
SIXRE Real estate SIXRE Real estate	SIXRE +0,73%	214,91	+1,55	+0,73%	—	213,36	213,36	215,54	212,77	—	—
SIXT Technology SIXT Technology	SIXT −1,82%	3.175,31	−58,87	−1,82%	—	3.234,18	3.171,86	3.195,36	3.145,46	—	—
SIXU Utilities SIXU Utilities	SIXU +0,19%	937,42	+1,77	+0,19%	—	935,65	937,31	941,44	933,16	—	—
SIXV Health care SIXV Health care	SIXV +0,19%	1.451,98	+2,72	+0,19%	—	1.449,26	1.454,77	1.462,65	1.448,97	—	—
SIXY Discretionary SIXY Discretionary	SIXY −0,60%	2.368,04	−14,41	−0,60%	—	2.382,45	2.371,19	2.380,45	2.364,46	—	—

NVS:BCBA

Novartis

10.800,00 ARS

0,00%

(0,00) 1D

19. tra, 16:40:36 GMT -3 · ARS

Svi simboli

GDD

MAKS

	Simbol	Cijena	Promjena	Postotna promjena

Generiranje najvažnijih uvida za NVS...

Trž. kap.

296,22 mlr.

Količina

0,00

Dionice u optjecaju

2,03 mlr.

Broj djelatnika

75 tis.

Povezane dionice

Vijesti

Iz izvora na cijelom webu

CNBC

prije 2 sata

Novartis CEO on Q1 earnings miss

Yahoo Finance

prije 3 sata

Novartis Q1 Earnings & Revenues Miss Estimates, Stock Down

Yahoo Finance

prije 3 sata

Novartis Adds New Therapies As Shares Trade Below Analyst Value Targets

MEXC

prije 4 sata

Novartis (NVS) Stock Slips as Q1 Earnings Miss and CEO Flags Pricing Policy Risk

Profil

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia

Novartis – informacije

Glavni izvršni direktorVasant Narasimhan

Zaposlenici75,3 tis.

Osnovano29. velj 1996.

SjedišteBasel, Basel-grad, Švicarska

Sektor-

Web-lokacijanovartis.com

Sve vrijednosti su u valuti USD	ožu 2025.	lip 2025.	ruj 2025.	pro 2025.
Prihod	13,62 mlr.	14,84 mlr.	14,36 mlr.	13,86 mlr.
Trošak prodane robe	3,22 mlr.	3,32 mlr.	3,54 mlr.	3,54 mlr.
Trošak prihoda	3,22 mlr.	3,32 mlr.	3,54 mlr.	3,54 mlr.
Izdaci za istraživanje i razvoj	2,37 mlr.	2,62 mlr.	2,86 mlr.	2,84 mlr.
Ukupni izdaci za istraživanje i razvoj	-	-	-	-
Izdaci za prodaju, opći i administrativni izdaci	3,06 mlr.	3,44 mlr.	3,30 mlr.	3,44 mlr.
Poslovni rashod	5,58 mlr.	6,05 mlr.	6,24 mlr.	6,46 mlr.
Ukupni poslovni rashodi	8,80 mlr.	9,37 mlr.	9,77 mlr.	10,00 mlr.
Poslovni prihod	4,82 mlr.	5,46 mlr.	4,58 mlr.	3,86 mlr.
Ostali neposlovni prihod	46,00 mil.	−13,00 mil.	−7,00 mil.	−130,00 mil.
Zarada prije poreza uključujući neuobičajene stavke	4,41 mlr.	4,53 mlr.	4,20 mlr.	3,22 mlr.
Zarada prije poreza isključujući neuobičajene stavke	4,59 mlr.	5,16 mlr.	4,29 mlr.	3,49 mlr.
Izdaci za porez na dohodak	798,00 mil.	507,00 mil.	266,00 mil.	814,00 mil.
Efektivna porezna stopa	18,11 %	11,19 %	6,34 %	25,30 %
Ostali poslovni rashodi	148,00 mil.	−4,00 mil.	70,00 mil.	190,00 mil.
Neto dohodak	3,61 mlr.	4,04 mlr.	3,93 mlr.	2,41 mlr.
Neto profitna marža	26,48 %	27,24 %	27,36 %	17,38 %
Zarada po dionici	2,28	2,42	2,25	2,03
Prihod od kamata i ulaganja	-	-	-	373,00 mil.
Izdaci za kamate	−270,00 mil.	−289,00 mil.	−281,00 mil.	−304,00 mil.
Neto izdaci za kamate	−270,00 mil.	−289,00 mil.	−281,00 mil.	69,00 mil.
Troškovi amortizacije i otpisa	-	-	-	-
Dobit prije kamata, poreza i amortizacije	5,91 mlr.	6,56 mlr.	5,78 mlr.	4,96 mlr.
Dobit ili gubitak od prodaje imovine	22,00 mil.	−67,00 mil.	81,00 mil.	80,00 mil.

AI sadržaj može uključivati pogreške. Saznajte više

PomoćPošaljite povratne informacijePrivatnost Uvjeti Odricanje od odgovornosti

Finance

Istraživanje